The purpose of this study is to determine the effects of the antiretroviral drugs efavirenz and ritonavir on human brain LAAM disposition in vivo.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
OTHER
Masking
NONE
Enrollment
10
intravenous administration of 15-20 mCi of \[11c\] LAAM.
Pretreatment with oral ritonavir for 3 days followed by intravenous administration of 15-20 mCI of \[11c\] LAAM.
Pretreatment with oral Efavirenz 600 mg orally every night x 14 days followed by intravenous administration of 15-20 mCI of \[11c\] LAAM.
Washington University School of Medicine
St Louis, Missouri, United States
cerebral [11C]LAAM distribution volume
Blood tests, MRI and PET data analysis and interpretation
Time frame: approximately 3 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.